Literature DB >> 24668

Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits.

L J Strausbaugh, M A Sande.   

Abstract

The therapy of Proteus mirabilis meningitis with gentamicin alone and in combination with chloramphenicol was studied in a rabbit model. Antibiotics were administered for 8 hr. Samples of serum and cerebrospinal fluid (CSF) obtained simultaneously were assayed at 2-hr intervals for antibiotic concentration and counts of bacteria in CSF. The percentage of penetration ([concentration in CSF divided by concentration in serum] x 100%) of gentamicin ranged from 14% to 23%, but very large dosages were required to kill bacteria in the CSF. Although the minimal bactericidal concentration (MBC) of gentamicin was 1 microgram/ml, killing in vivo occurred only when concentrations in CSF were 10--30 times the MBC. The high concentration required for bactericidal activity in vivo may be explained by the reduced pH of infected CSF (mean pH, 6.98; range, 6.69--7.18). The bactericidal action of gentamicin was abolished by the simultaneous administration of chloramphenicol. Titers of bacteria in CSF were reduced 2.60 log10 (mean) with gentamicin therapy vs. 0.92 log10 (mean) with combination (P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 24668     DOI: 10.1093/infdis/137.3.251

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Diagnosis and treatment of bacterial meningitis.

Authors:  H El Bashir; M Laundy; R Booy
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.

Authors:  Kameshwar Prasad; Nirendra Kumar Rai; Amit Kumar
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.

Authors:  W Kern; S L Kennedy; M Sachdeva; E R Sande; D Gunderson; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.

Authors:  M G Täuber; S Kunz; O Zak; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

5.  Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.

Authors:  B I Asmar; M Prainito; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

Review 6.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

7.  Deficient cerebrospinal fluid opsonization in experimental Escherichia coli meningitis.

Authors:  L L Bernhardt; M S Simberkoff; J J Rahal
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

8.  Rapid differentiation of bacterial meningitides by direct gas-liquid chromatography.

Authors:  H Thadepalli; P K Gangopadhyay; A Ansari; G D Overturf; V K Dhawan; A K Mandal
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

9.  Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.

Authors:  W M Scheld; R S Brown; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

Authors:  W M Scheld; M A Sande
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.